Detalhe da pesquisa
1.
Pharmacology of Chimeric Antigen Receptor-Modified T Cells.
Annu Rev Pharmacol Toxicol
; 61: 805-829, 2021 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035447
2.
The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity.
Mol Ther Oncolytics
; 27: 288-304, 2022 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458202